2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on Waldenstrom Macroglobulinemia: Clinical Benefit Comparison of Zanubrutinib vs. Ibrutinib

168 views
August 25, 2020
Comments 0
Login to view comments. Click here to Login